Moreover, Camp−/− permitted faster tumor growth than wild-type controls in two different xenograft tumor mouse models (murine B16 melanoma and RMA-S lymphoma) that exclude an observed perforin deficiency [16]. The gene discussed is CAMP; the disease is neoplasm.